Trial Profile
An Active-Control, Randomized, Prospective, Multicenter, Phase-III Comparative Clinical Study to investigate, Efficacy, Safety and Tolerability of Linezolid 1200mg SR Tablet OD when compared with Linezolid 600mg Tablet BD in subjects suffering with Uncomplicated Skin and Soft Tissue Infections
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Aug 2016
Price :
$35
*
At a glance
- Drugs Linezolid (Primary)
- Indications Bacterial infections; Skin and soft tissue infections
- Focus Registrational; Therapeutic Use
- Sponsors Inventia Healthcare
- 29 Sep 2013 New trial record